Development of a novel cytomedical treatment that can protect entrapped cells from host humoral immunity

Cell Transplantation

Volumn 11, Issue 8, 2002, Pages 787-798

  Suzuki, Ryo ^a   Yoshioka, Yasuo ^a   Kitano, Etsuko ^b   Yoshioka, Tatsunobu ^a   Oka, Hiroaki ^a   Okamoto, Takayuki ^a   Okada, Naoki ^c   Tsutsumi, Yasuo ^a   Nakagawa, Shinsaku ^a   Miyazaki, Jun ichi ^d   Kitamura, Hajime ^b   Mayumi, Tadanori ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Agarose microbeads; Cell therapy; Complement; Cytomedicine; Humoral immunity; Polyvinyl sulfate (PVS)

Indexed keywords

AGAROSE; ALGINIC ACID; CARBOXYMETHYLCELLULOSE; CD59 ANTIGEN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; DECAY ACCELERATING FACTOR; DEXTRAN; DEXTRAN SULFATE; GLUCOSE; HEXADIMETHRINE BROMIDE; IMMUNOGLOBULIN; INSULIN; LATEX; MACROGOL; MEMBRANE COFACTOR PROTEIN; POLYACRYLAMIDE; POLYACRYLIC ACID; POLYAMINE; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; POLYSTYRENE DERIVATIVE; POLYVINYL DERIVATIVE; POLYVINYL SULFATE; POVIDONE; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ARTICLE; CELL ENCAPSULATION; CELL PROTECTION; CELL TRANSPLANTATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DIABETES MELLITUS; ERYTHROCYTE; HEMOLYSIS; HUMORAL IMMUNITY; INSULIN RELEASE; MICROENCAPSULATION; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RABBIT; SHEEP;

ANIMALIA; MURINAE; ORYCTOLAGUS CUNICULUS; OVIS ARIES;

EID: 0036981064     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000002783985305     Document Type: Article

References (33)

1. Aoyama, T.; Ino, Y.; Ozeki, M.; Oda, M,; Sato, T.; Koshiyama, Y.; Suzuki, S.; Fujita, M. Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn. J. Pharmacol. 35:203-227; 1984.
2. Efrat, S. Cell-based therapy for insulin-dependent diabetes mellitus. Eur. J. Endocrinol. 138:129-133; 1998.
3. Fuchs, E.; Segre, J. A. Stem cells: A new lease on life. Cell 100:143-155; 2000.
4. Fujita, T.; Inoue, T.; Ogawa, K.; Iida, K.; Tamura, N. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J. Exp. Med. 166:1221-1228; 1987.
5. Gros, L.; Montoliu, L.; Riu, E.; Lebrigand, L.; Bosch, F. Regulated production of mature insulin by non-beta-cells. Hum. Gene Ther. 8:2249-2259; 1997.
6. Inoue, K.; Gu, Y. J.; Hayashi, H.; Shinohara, S.; Aung, T.; Tun, T.; Wang, W. J.; Setoyama, H.; Kawakami, Y.; Kaji, H.; Imamura, M.; Morikawa, N.; Iwata, H.; Ikada, Y. Pig-to-rat xenotransplantation with mesh-reinforced polyvinyl alcohol bag: Efficacy of agarose gel. Transplant. Proc. 28:1422-1423; 1996.
7. Iwata, H.; Murakami, Y.; Ikada, Y. Control of complement activities for immunoisolation. Ann. NY Acad. Sci. 875:7-23; 1999.
8. Iwata, H.; Takagi, T.; Kobayashi, K.; Oka, T.; Tsuji, T.; Ito, F. Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J. Biomed. Mater. Res. 28:1201-1207; 1994.
9. Kamada, H.; Tsutsumi, Y.; Yamamoto, Y.; Kihira, T.; Kaneda, Y.; Mu, Y.; Kodaira, H.; Tsunoda, S. I.; Nakagawa, S.; Mayumi, T. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice. Cancer Res. 60:6416-6420; 2000.
10. Kobayashi, E.; Kitano, E.; Kitamura, H. A novel assay for serum complement activity: C42 generation assay. Int. Arch. Allergy Immunol. 120:71-77; 1999.
11. Lacy, P. E.; Hegre, O. D.; Gerasimidi-Vazeou, A.; Gentile, F. T.; Dionne, K. E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254:1782-1784; 1991.
12. Leventhal, J. R.; Dalmasso, A. P.; Cromwell, J. W.; Platt, J. L.; Manivel, C. J.; Bolman, R. M., 3rd; Matas, A. J. Prolongation of cardiac xenograft survival by depletion of complement Transplantation 55:857-856; 1993.
13. McDonald, J. W.; Liu, X. Z.; Qu, Y.; Liu, S.; Mickey, S. K.; Turetsky, D.; Gottlieb, D. I.; Choi, D. W. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5:1410-1412; 1999.
14. Miyagawa, S.; Shirakura, R.; Matsumiya, G.; Fukushima, N.; Nakata, S.; Matsuda, H.; Matsumoto, M.; Kitamura, H.; Seya, T. Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT175. Transplantation 55:709-713; 1993.
15. Miyamoto, H.; Okada, N.; Yoshioka, T.; Suzuki, R.; Sakamoto, K.; Katsume, A.; Saito, H.; Tsutsumi, Y.; Kubo, K.; Nakagawa, S.; Ohsugi, Y.; Mayumi, T. Prolongation of the effective duration of cytomedical therapy by re-injecting SK2 hybridoma cells microencapsulated within alginate-poly(L)lysine-alginate membranes into human interleukin-6 transgenic mice. Biol. Pharm. Bull. 22:295-297; 1999.
16. Miyazaki, J.; Araki, K.; Yamato, E.; Ikegami, H.; Asano, T.; Shibasaki, Y.; Oka, Y.; Yamamura, K. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132; 1990.
17. Morgan, B. P. Complement methods and protocols. Totowa, NJ: Human Press; 2000.
18. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63; 1983.
19. Oberpenning, F.; Meng, J.; Yoo, J. J.; Atala, A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol. 17:149-155; 1999.
20. Ohgawara, H.; Hirotani, S.; Miyazaki, J.; Teraoka, S. Membrane immunoisolation of a diffusion chamber for bioartificial pancreas. Artif. Organs 22:788-794; 1998.
21. Okada, N.; Harada, R.; Fujita, T.; Okada, H. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement. J. Immunol. 143:2262-2266; 1989.
22. Okada, N.; Miyamoto, H.; Kaneda, Y.; Yamamoto, Y.; Katsume, A.; Saito, H.; Yorozu, K.; Ueda, O.; Tsutsumi, Y.; Nakagawa, S.; Oshugi, Y.; Mayumi, T. Medical application of microencapsulating hybridoma cells in agarose microbeads "Cytomedicine"; therapeutic effect on IgG1 plasmacytosis and mesangio-proliferative glomerrulonephritis in the interleukin-6 transgenic mouse. J. Controlled Release 44:195-200; 1997.
23. Okada, N.; Miyamoto, H.; Yoshioka, T.; Katsume, A.; Saito, H.; Yorozu, K.; Ueda, O.; Itoh, N.; Mizuguchi, H.; Nakagawa, S.; Oshugi, Y.; Mayumi, T. Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane. Biochim. Biophys. Acta 1360:53-63; 1997.
24. Okada, N.; Miyamoto, H.; Yoshioka, T.; Katsume, A.; Saito, H.; Yorozu, K.; Ueda, O.; Nakagawa, S.; Oshugi, Y.; Mayumi, T. Therapeutic effect of cytomedicine on mesangio-proliferative glomerulonephritis in human interleukin-6 transgenic mice. Biol. Pharm. Bull. 255-258; 1997.
25. Okada, N.; Miyamoto, H.; Yoshioka, T.; Sakamoto, K.; Katsume, A.; Saito, H.; Nakagawa, S.; Ohsugi, Y.; Mayumi, T. Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA) membrane following allogeneic transplantation. Biochem. Biophys. Res. Commun. 230:524-527; 1997.
26. O'Keefe, S. J.; Tamura, J.; Kincaid, R. L.; Tocci, M. J.; O'Neill, E. A. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357:692-694; 1992.
27. Pascual, M.; Plastre, O.; Montdargent, B.; Labarre, D.; Schifferli, J. A. Specific interactions of polystyrene biomaterials with factor D of human complement. Biomaterials 14:665-670; 1993.
28. Pruitt, S. K.; Kirk, A. D.; Bollinger, R, R.; Marsh, H. C., Jr.; Collins, B. H.; Levin, J. L.; Mault, J. R.; Heinle, J. S.; Ibrahim, S.; Rudolph, A. R.; et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57:363-370; 1994.
29. Setoyama, H.: Murakami, Y.; Inoue, K.; Iwata, H.; Kitamura, H.; Shimada, T.; Kaji, H.; Ikada, Y.; Imamura, M. Extracorporeal circulation with an anticomplement synthetic polymer prolongs guinea pig-to-rat cardiac xenograft survival. Transplant. Proc. 31:2818-2822; 1999.
30. Seya, T.; Okada, M.; Matsumoto, M.; Hong, K. S.; Kinoshita, T.; Atkinson, J. P. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP). Mol. Immunol. 28:1137-1147; 1991.
31. Studer, L.; Tabar, V.; McKay, R. D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1:290-295; 1998.
32. Sun, Y.; Ma, X.; Zhou, D.; Vacek, I.; Sun, A. M. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 98:1417-1422; 1996.
33. Wuillemin, W. A.; te Velthuis, H.; Lubbers, Y. T.; de Ruig, C. P.; Eldering, E.; Hack, C. E. Potentiation of C1 inhibitor by glycosaminoglycans: Dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. J. Immunol. 159:1953-1960; 1997.